Literature DB >> 32955630

Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis.

Wanruchada Katchamart1, Pongthorn Narongroeknawin2, Ngamsiree Sukprasert3, Wanwisa Chanapai4, Ananya Srisomnuek4.   

Abstract

INTRODUCTION/
OBJECTIVES: To determine the prevalence and factors associated with medication noncompliance by Thai patients with rheumatoid arthritis (RA).
METHODS: This prospective cohort study enrolled 443 adult RA patients (≥ 18 years) who were followed up at the outpatient rheumatology clinics of Siriraj Hospital and Phramongkutklao Hospital between May 2018 and December 2019. Medication noncompliance was assessed using the Compliance Questionnaire for Rheumatology-19 (CQR-19). A score of 0 indicated complete noncompliance, whereas a score of 100 indicated a perfect compliance. An unsatisfactory compliance was arbitrarily defined as a taking compliance of ≤ 80%.
RESULTS: The prevalence of medication noncompliance was 22.1%. The most common cause was forgetting to take medications due to a busy work schedule. In a univariate analysis, the factors that were significantly related to medication noncompliance were age, income, number of comorbidities, functional status as measured by the Health Assessment Questionnaire (HAQ), number of prescribed pills per day, and number of types of prescribed medications per day. In a subsequent backward stepwise multiple logistic regression analysis, only 2 factors were found to be negatively associated with medication noncompliance: age (risk ratio, 0.98; 95% CI, 0.96-0.99; p, 0.048) and HAQ (risk ratio, 0.62; 95% CI, 0.39-0.98; p, 0.041).
CONCLUSIONS: Medication noncompliance is common in patients with RA. As this may lead to unfavorable outcomes, patient education related to drug compliance should be addressed and emphasized in daily practice. Key Points • Medication noncompliance is common in patients with RA. • Forgetting to take pills was the most frequent explanation offered for noncompliance. • All patients should be strongly encouraged to comply with the recommended drug regimens.

Entities:  

Keywords:  Compliance-Questionnaire-Rheumatology; Medication compliance; Rheumatoid arthritis

Mesh:

Substances:

Year:  2020        PMID: 32955630     DOI: 10.1007/s10067-020-05409-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.

Authors:  Theresa M Hunter; Natalie N Boytsov; Xiang Zhang; Krista Schroeder; Kaleb Michaud; Andre B Araujo
Journal:  Rheumatol Int       Date:  2017-04-28       Impact factor: 2.631

2.  Compliance with treatment of rheumatoid arthritis.

Authors:  Raili Müller; Riina Kallikorm; Kaja Põlluste; Margus Lember
Journal:  Rheumatol Int       Date:  2011-09-24       Impact factor: 2.631

3.  Predictors of Medication Adherence in Patients with Rheumatoid Arthritis.

Authors:  Elizabeth Salt; Susan K Frazier
Journal:  Drug Dev Res       Date:  2011-12       Impact factor: 4.360

4.  Factors affecting drug treatment compliance in patients with rheumatoid arthritis.

Authors:  Reyhan Tuncay; Emel Eksioglu; Banu Cakir; Eda Gurcay; Aytul Cakci
Journal:  Rheumatol Int       Date:  2007-01-11       Impact factor: 2.631

5.  Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study.

Authors:  F Viller; F Guillemin; S Briançon; T Moum; T Suurmeijer; W van den Heuvel
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

6.  Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis.

Authors:  Maria D Mjaavatten; Helga Radner; Kazuki Yoshida; Nancy A Shadick; Michelle L Frits; Christine K Iannaccone; Tore K Kvien; Michael E Weinblatt; Daniel H Solomon
Journal:  J Rheumatol       Date:  2014-10-15       Impact factor: 4.666

7.  The influence of medication beliefs and other psychosocial factors on early discontinuation of disease-modifying anti-rheumatic drugs.

Authors:  M Wong; D Mulherin
Journal:  Musculoskeletal Care       Date:  2007-09

8.  Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.

Authors:  Bart J F van den Bemt; Frank H J van den Hoogen; Bart Benraad; Yechiel A Hekster; Piet L C M van Riel; Wim van Lankveld
Journal:  J Rheumatol       Date:  2009-09-01       Impact factor: 4.666

9.  Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden.

Authors:  Lars Erik Kristensen; Tore Saxne; Jan-Ake Nilsson; Pierre Geborek
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability.

Authors:  Virginia Pascual-Ramos; Irazú Contreras-Yáñez; Antonio R Villa; Javier Cabiedes; Marina Rull-Gabayet
Journal:  Arthritis Res Ther       Date:  2009-02-19       Impact factor: 5.156

View more
  2 in total

1.  Validity and Reliability of the Thai Version of the 19-Item Compliance-Questionnaire-Rheumatology.

Authors:  Saranya Panichaporn; Wanwisa Chanapai; Ananya Srisomnuek; Phakhamon Thaweeratthakul; Wanruchada Katchamart
Journal:  Patient Prefer Adherence       Date:  2022-08-17       Impact factor: 2.314

Review 2.  An Overview on Causes of Nonadherence in the Treatment of Rheumatoid Arthritis: Its Effect on Mortality and Ways to Improve Adherence.

Authors:  Tutul Chowdhury; Jui Dutta; Pharlin Noel; Ratul Islam; Gael Gonzalez-Peltier; Samzorna Azad; Malavika Shankar; Aditya Keerthi Rayapureddy; Padmaja Deb Roy; Nicole Gousy; Khondokar N Hassan
Journal:  Cureus       Date:  2022-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.